Market Overview

UPDATE: Oppenheimer Raises PT to $37 on Oracle Following Positive Q2 Results

Share:
Related ORCL
Deutsche Bank: MongoDB Isn't A Near-Term Threat To Oracle
Salesforce's 'Magic Of 30' Is Alive, BofA Says
Pay Up For Evolent Health's IPO (Seeking Alpha)

Oppenheimer reiterated its Outperform rating on Oracle (NASDAQ: ORCL) and increased its price target from $36 to $37.

Oppenheimer said, "We believe Oracle's internally-driven new product-cycles are gaining traction within the base, and as the uptake becomes more meaningful (over the next 12-18 months) it should start yielding greater operating leverage and serve as a catalyst to drive a revaluation of the stock multiple."

Oracle closed at $32.88 on Tuesday.

Latest Ratings for ORCL

DateFirmActionFromTo
May 2015SunTrust Robinson HumphreyInitiates Coverage onNeutral
Mar 2015RBC CapitalUpgradesSector PerformOutperform
Mar 2015BarclaysMaintainsOverweight

View More Analyst Ratings for ORCL
View the Latest Analyst Ratings

Posted-In: OppenheimerAnalyst Color Price Target Pre-Market Outlook Analyst Ratings

 

Related Articles (ORCL)

Around the Web, We're Loving...